Friday, September 19th, 2025

KPJ Healthcare (KPJ MK) – on track to achieve a 20% year-on-year growth in medical tourism revenue for 2024, with the Malaysia Healthcare Travel Council targeting a revenue of RM2.4 billion for the year.

KPJ Healthcare (KPJ MK) – Update

Share Price: RM2.07 | Target Price: RM1.90 | Rating: HOLD

Company Overview

  • KPJ Healthcare is Malaysia’s largest private hospital operator.
  • The company is undergoing a transformation programme aimed at strengthening its market position, enhancing operational efficiencies, and boosting profitability.

Key Highlights

  1. Transformation Programme:
    • KPJ’s medium-term growth is underpinned by both brownfield capacity expansions and its five-year transformation plan.
    • This transformation includes pillars such as branding, culture activation, and digitalisation.
    • A key feature of this digital-first approach is the “One Patient, One Record” concept, consolidating medical information across its hospital network into a single, comprehensive patient record accessible throughout its facilities. This initiative is further supported by its mobile app.
  2. Capacity Building:
    • KPJ aims to increase capacity to 5,000 beds by 2028 from the current 3,733 beds.
    • KPJ is effectively managing asset optimisation through hospital gestation and asset divestment, improving performance across its portfolio.
  3. Medical Tourism Growth:
    • KPJ is strategically focusing on medical tourism, targeting secondary markets such as Bangladesh, India, MENA, and China.
    • The company is on track to achieve a 20% year-on-year growth in medical tourism revenue for 2024, with the Malaysia Healthcare Travel Council targeting a revenue of RM2.4 billion for the year.
  4. Financial Performance:
    • Most of KPJ’s loss-making hospitals are expected to break even by year-end, except for the Miri Hospital, which continues to face challenges in attracting consultants.
    • KPJ is expecting continued financial improvement, with earnings supported by its expansion efforts and medical tourism growth.

Valuation & Recommendation:

  • KPJ’s target price remains at RM1.90, with a HOLD rating maintained. While the company’s transformation efforts and growth strategies are promising, most of these outcomes have already been priced into the stock.

Key Risks:

  • Potential delays in hospital openings or regulatory changes.
  • The challenge of managing higher operating costs while maintaining profitability.

Conclusion:

  • KPJ Healthcare’s transformation programme is proceeding well, with promising growth in capacity and medical tourism. However, the positive outcomes from these initiatives are largely priced into the current share price, resulting in a HOLD recommendation at a target price of RM1.90.Thank you

Singapore Manufacturing Steady in July 2025: Strong Electronics Growth Faces US Tariff Risks

CGS International August 26, 2025 Singapore’s Manufacturing Sector Surges in July: Electronics Lead Growth Amid Tariff Uncertainties Strong Industrial Rebound in July 2025 Surpasses Market Expectations Singapore’s manufacturing sector delivered a robust performance in...

Unlocking Growth: Pavilion REIT’s Promising Outlook Amidst Market Challenges

Date of Report 25 October 2024 Broker Name UOB Kay Hian Company Overview Pavilion REIT is a real estate investment trust (REIT) with a portfolio that includes the iconic Pavilion Shopping Mall and the...

WuXi AppTec (2359 HK) Delivers Strong 1H25 Results: Revenue Jumps 20.6%, Ups Guidance, Target Price HK$146 – Buy Recommendation

UOB Kay Hian Date of Report: July 30, 2025 WuXi AppTec Surges on Robust 1H25 Results: Strong Growth in CRDMO Services and TIDES Business Drives Upbeat Forecast Overview: Exceptional Performance Fuels Bullish Outlook WuXi...